Meet the team advancing LND therapeutics.
Our leadership blends clinical rigor, operational excellence, and data-driven innovation to deliver safe microbiome therapies at scale.
Saman Maleki
CEO
Leads clinical strategy, partnerships, and program development for LND Therapeutics. (Placeholder—send details and I’ll update.)
Michael S. Silverman
CMO
MD, FRCP, FACP. Chair/Chief of Infectious Diseases at Western University (London, Ontario). Provides clinical leadership for microbiome therapeutics and trial-aligned medical strategy.
Seema
COO
Oversees operations across donor program logistics, manufacturing readiness, partner execution, and quality/compliance workflows to support clinical-scale delivery.
Behnam Jabbarizadeh
CTO
Leads LND’s data and technology stack, including multi-omics pipelines, metagenomics and functional (EC/pathway) analytics, dashboards, and reproducible reporting for clinical and research partners.
Built for clinical excellence
Beyond leadership, dedicated experts in quality systems, donor advocacy, and data science support every therapeutic program.
Donor engagement
Coordinators ensure ethical sourcing, follow-ups, and reliable supply.
Quality & compliance
GMP-aligned protocols and validation guard every manufacturing step.
Clinical operations
Program managers oversee trial execution, timelines, and partner support.
Data science
Analysts connect multi-omics insights to patient outcomes and trial learning.